⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Official Title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region

Study ID: NCT00017511

Study Description

Brief Summary: RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no therapy in treating dry mouth caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating patients who have dryness of the mouth caused by radiation therapy for head and neck cancer.

Detailed Description: OBJECTIVES: * Compare the efficacy of cevimeline vs placebo, in terms of dryness of the oral cavity and salivary flow, in patients with xerostomia secondary to radiotherapy for cancers in the head and neck region. * Assess the safety of this drug in these patients. OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are randomized to 1 of 2 treatment arms. * Arm I: Patients receive oral cevimeline 3 times daily for 12 weeks in the absence of unacceptable toxicity. * Arm II: Patients receive oral placebo as in arm I. PROJECTED ACCRUAL: A total of 280 patients (140 per arm) will be accrued for this study.

Keywords

stage I salivary gland cancer
stage II salivary gland cancer
stage III salivary gland cancer
stage IV salivary gland cancer
recurrent salivary gland cancer
untreated metastatic squamous neck cancer with occult primary
recurrent metastatic squamous neck cancer with occult primary
metastatic squamous neck cancer with occult primary squamous cell carcinoma
oral complications
stage I squamous cell carcinoma of the lip and oral cavity
stage I basal cell carcinoma of the lip
stage I verrucous carcinoma of the oral cavity
stage I mucoepidermoid carcinoma of the oral cavity
stage I adenoid cystic carcinoma of the oral cavity
stage II squamous cell carcinoma of the lip and oral cavity
stage II basal cell carcinoma of the lip
stage II verrucous carcinoma of the oral cavity
stage II mucoepidermoid carcinoma of the oral cavity
stage II adenoid cystic carcinoma of the oral cavity
stage III squamous cell carcinoma of the lip and oral cavity
stage III basal cell carcinoma of the lip
stage III verrucous carcinoma of the oral cavity
stage III mucoepidermoid carcinoma of the oral cavity
stage III adenoid cystic carcinoma of the oral cavity
stage IV squamous cell carcinoma of the lip and oral cavity
stage IV basal cell carcinoma of the lip
stage IV verrucous carcinoma of the oral cavity
stage IV mucoepidermoid carcinoma of the oral cavity
stage IV adenoid cystic carcinoma of the oral cavity
recurrent squamous cell carcinoma of the lip and oral cavity
recurrent basal cell carcinoma of the lip
recurrent verrucous carcinoma of the oral cavity
recurrent mucoepidermoid carcinoma of the oral cavity
recurrent adenoid cystic carcinoma of the oral cavity
stage I squamous cell carcinoma of the oropharynx
stage I lymphoepithelioma of the oropharynx
stage II squamous cell carcinoma of the oropharynx
stage II lymphoepithelioma of the oropharynx
stage III squamous cell carcinoma of the oropharynx
stage III lymphoepithelioma of the oropharynx
stage IV squamous cell carcinoma of the oropharynx
stage IV lymphoepithelioma of the oropharynx
recurrent squamous cell carcinoma of the oropharynx
recurrent lymphoepithelioma of the oropharynx
stage I squamous cell carcinoma of the nasopharynx
stage I lymphoepithelioma of the nasopharynx
stage II squamous cell carcinoma of the nasopharynx
stage II lymphoepithelioma of the nasopharynx
stage III squamous cell carcinoma of the nasopharynx
stage III lymphoepithelioma of the nasopharynx
stage IV squamous cell carcinoma of the nasopharynx
stage IV lymphoepithelioma of the nasopharynx
recurrent squamous cell carcinoma of the nasopharynx
recurrent lymphoepithelioma of the nasopharynx
stage I squamous cell carcinoma of the hypopharynx
stage II squamous cell carcinoma of the hypopharynx
stage III squamous cell carcinoma of the hypopharynx
stage IV squamous cell carcinoma of the hypopharynx
recurrent squamous cell carcinoma of the hypopharynx
stage I squamous cell carcinoma of the larynx
stage I verrucous carcinoma of the larynx
stage II squamous cell carcinoma of the larynx
stage II verrucous carcinoma of the larynx
stage III squamous cell carcinoma of the larynx
stage III verrucous carcinoma of the larynx
stage IV squamous cell carcinoma of the larynx
stage IV verrucous carcinoma of the larynx
recurrent squamous cell carcinoma of the larynx
recurrent verrucous carcinoma of the larynx
stage I squamous cell carcinoma of the paranasal sinus and nasal cavity
stage I inverted papilloma of the paranasal sinus and nasal cavity
stage I midline lethal granuloma of the paranasal sinus and nasal cavity
stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity
stage II squamous cell carcinoma of the paranasal sinus and nasal cavity
stage II inverted papilloma of the paranasal sinus and nasal cavity
stage II midline lethal granuloma of the paranasal sinus and nasal cavity
stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity
stage III squamous cell carcinoma of the paranasal sinus and nasal cavity
stage III inverted papilloma of the paranasal sinus and nasal cavity
stage III midline lethal granuloma of the paranasal sinus and nasal cavity
stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity
stage IV inverted papilloma of the paranasal sinus and nasal cavity
stage IV midline lethal granuloma of the paranasal sinus and nasal cavity
stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity
recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
recurrent inverted papilloma of the paranasal sinus and nasal cavity
recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
radiation toxicity

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States

Mobile Infirmary Medical Center, Mobile, Alabama, United States

Cranial Pain Research, Tucson, Arizona, United States

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Alta Bates Comprehensive Cancer Center, Berkeley, California, United States

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Chao Family Comprehensive Cancer Center, Orange, California, United States

Radiation Oncology Center - Sacramento, Sacramento, California, United States

Rebecca and John Moores UCSD Cancer Center, San Diego, California, United States

Stanford University Medical Center, Stanford, California, United States

Colorado Otolaryngology Associates, Colorado Springs, Colorado, United States

University of Connecticut Health Center, Farmington, Connecticut, United States

Walter Reed Army Medical Center, Washington, District of Columbia, United States

Innovative Medical Research of South Florida, Inc., Miami, Florida, United States

Medical College of Georgia Hospital and Clinics, Augusta, Georgia, United States

Kootenai Medical Center, Coeur d'Alene, Idaho, United States

University of Illinois at Chicago, Chicago, Illinois, United States

University of Chicago Cancer Research Center, Chicago, Illinois, United States

Evanston Northwestern Health Care, Evanston, Illinois, United States

University of Kansas Medical Center, Kansas City, Kansas, United States

Central Baptist Hospital, Lexington, Kentucky, United States

James Graham Brown Cancer Center, Louisville, Kentucky, United States

, Louisville, Kentucky, United States

Tulane Cancer Center, New Orleans, Louisiana, United States

Harbor Hospital Center, Baltimore, Maryland, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Ear, Nose, and Throat Specialty Care of Minnesota, P.A., Minneapolis, Minnesota, United States

University of Minnesota School of Dentistry, Minneapolis, Minnesota, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

University of Missouri, Columbia, Missouri, United States

Siteman Cancer Center, Saint Louis, Missouri, United States

University of Nebraska Medical Center, Lincoln, Nebraska, United States

University of Nebraska Medical Center, Omaha, Nebraska, United States

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Hackensack University Medical Center, Hackensack, New Jersey, United States

Monmouth Medical Center, Long Branch, New Jersey, United States

Professional Otolaryngology Associates, Voorhees, New Jersey, United States

Albert Einstein Clinical Cancer Center, Bronx, New York, United States

North Shore University Hospital, Manhasset, New York, United States

NYU - David B. Kriser Dental Center, New York, New York, United States

Mount Sinai Medical Center, NY, New York, New York, United States

James P. Wilmot Cancer Center, Rochester, New York, United States

State University of New York at Stony Brook School of Medicine, Stony Brook, New York, United States

State University of New York - Upstate Medical University, Syracuse, New York, United States

Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Comprehensive Cancer Center at Gaston Memorial, Gastonia, North Carolina, United States

Matthews Radiation Oncology Center, Matthews, North Carolina, United States

Clinical Research of Winston Salem, Winston-Salem, North Carolina, United States

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

Oregon Cancer Institute, Portland, Oregon, United States

Geisinger Medical Center, Danville, Pennsylvania, United States

Head and Neck Associates, Havertown, Pennsylvania, United States

Associated Otolaryngologist, Palmyra, Pennsylvania, United States

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

Eye and Ear Institute, Pittsburgh, Pennsylvania, United States

Medical University of South Carolina, Charleston, South Carolina, United States

Memorial Hospital Cancer Center - Chattanooga, Chattanooga, Tennessee, United States

MultiSpecialty Clinical Research, Johnson City, Tennessee, United States

Dial Research Associates, Inc., Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Baylor College of Dentistry, Dallas, Texas, United States

University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

Cancer Physicians Associates, PA, Laredo, Texas, United States

Latter Day Saints Hospital, Salt Lake City, Utah, United States

, McLean, Virginia, United States

Seattle Institute for Biomedical and Clinical Research, Seattle, Washington, United States

Madigan Army Medical Center, Tacoma, Washington, United States

Southwest Washington Medical Center, Vancouver, Washington, United States

Contact Details

Name: Robert Vitti, MD

Affiliation: Daiichi Sankyo

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: